The long Q-T interval and syndromes

Area of Science:

• Cardiology
• Electrophysiology
• Molecular Biology

Background:

• Long Q-T syndrome (LQTS) presents clinically as acquired, congenital, or miscellaneous forms.
• Therapies for LQTS vary based on etiology, targeting drugs for acquired forms and sympathetic activity for congenital forms.
• Pathologic disparities in myocardial excitation-contraction coupling and sympathetic nervous system activity are implicated in LQTS arrhythmogenesis.

Purpose of the Study:

• To review the current understanding of the electrical mechanisms underlying arrhythmias in Long Q-T syndrome.
• To explore potential alternative electrophysiological sources contributing to ventricular arrhythmias in LQTS.
• To highlight the need for further clinical validation of proposed mechanisms and the development of novel therapeutic strategies.

Main Methods:

• Review of existing literature on LQTS pathophysiology and electrophysiology.
• Analysis of proposed electrical mechanisms for arrhythmogenesis during Q-T and Q-U intervals.
• Consideration of evidence from membrane-level studies (e.g., canine Purkinje fibers) and clinical observations.

Main Results:

• Current understanding points to disparities in myocardial repolarization and sympathetic overactivity as primary drivers of LQTS arrhythmias.
• Alternative mechanisms, including altered ventricular activation, desynchronized repolarization, and afterdepolarizations, are proposed as potential contributors.
• Limited clinical evidence exists for some proposed mechanisms, necessitating further investigation.

Conclusions:

• Further clinical research is essential to validate proposed electrophysiological mechanisms in LQTS.
• Advancements in understanding LQTS arrhythmias will likely lead to improved management strategies for malignant ventricular arrhythmias.
• Development of novel drugs targeting specific ion channel functions is an active area of investigation for LQTS treatment.